key: cord-0925946-p0mj8o23 authors: Yu, Xiaomei; He, Wenbo; Wang, Lang; Bao, Mingwei; Liu, Huafen; Zhou, Jiali; Jiang, Hong title: Profiles of liver function abnormalities in elderly patients with Coronavirus Disease 2019 date: 2020-08-03 journal: Int J Clin Pract DOI: 10.1111/ijcp.13632 sha: 91c4fb18149dda5cb5d5017915b6bd262d0fb5c7 doc_id: 925946 cord_uid: p0mj8o23 BACKGROUND: The profiles of liver function abnormalities in COVID‐19 patients need to be clarified. METHODS: In this retrospective study, consecutive COVID‐19 patients over 60 years old in Renmin Hospital of Wuhan University from Jan 1 to Feb 6 were included. Data of demographics, clinical characteristics, comorbidities, laboratory tests, medications and outcomes were collected and analyzed. Sequential alterations of serum alanine aminotransferase (ALT) were monitored. RESULTS: 330 patients were included and classified into two groups with normal (n=234) or elevated ALT (n=96). There were fewer females (40.6% vs 54.7%, P=0.020) and more critical cases (30.2% vs. 19.2%, P=0.026) in patients with elevated ALT compared to the normal group. Higher levels of bacterial infection indices (e.g. white blood cell count, neutrophil count, C‐reactive protein and procalcitonin) were observed in the elevated group. Spearman correlation showed that both ALT and AST levels were positively correlated with those indices of bacterial infection. No obvious effects of medications on ALT abnormalities were found. In patients with elevated ALT, most ALT elevations were mild and transient. 59.4% of the patients had ALT concentrations of 41–100 U/L, while only a few patients (5.2%) had high serum ALT concentrations above 300 U/L. ALT elevations occurred at 13 (10–17) days and recovered at 28 (18–35) days from disease onset. For most patients, the elevation of serum ALT levels occurred at 6–20 days after disease onset and reached their peak values within a similar time frame. The recovery of serum ALT levels to normal frequently occurred at 16–20 days or 31–35 days after disease onset. CONCLUSIONS: Liver function abnormalities were observed in 29.1% of the elderly COVID‐19 patients, which were slightly and transient in most cases. Liver function abnormalities in COVID‐19 may be correlated with bacterial infection. Since December 2019, Coronavirus Disease 2019 (COVID-19) caused by a novel coronavirus infection, 1 which was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has being spreading rapidly around the world. 750,890 patients have been infected and 36,405 have died worldwide as of March 31, 2020. 2 Several complications have been reported in studies of COVID-19, among which liver function abnormalities were commonly observed. [3] [4] [5] [6] The reported incidence of liver function abnormalities in COVID-19 was 14%-53%. 7,8 However, the detailed characteristics and temporal changes of liver function abnormalities in COVID- 19 have not been reported. This study aims to illustrate the profile of liver function abnormalities in elderly patients with COVID-19, which might help with clinical practice. The patients in this retrospective study came from a case series in a descriptive study recently reported by us, 9 which included consecutive cases of COVID-19 over 60 years old admitted from Jan 1 to Feb 6 in Renmin Hospital of Wuhan University in Wuhan, China. The diagnosis of COVID-19 was according to the Interim guidance for novel coronavirus pneumonia established by National Health Commission of the People's Republic of China. 10 Patients without measurements of liver function were excluded. The severity of disease were classified into four groups including mild, moderate, severe and critical based on the criteria reported by the WHO-China Joint Mission on This study was in accordance with the edicts of the Declaration of Helsinki and approved by the Ethics Committee of Renmin Hospital of Wuhan University (No. WDRY2020-K032). Real-time PCR was performed to detect the SARS-CoV-2 specific nucleic acid for the diagnosis of COVID-19. Patients' medical records were carefully reviewed and analyzed by three trained physicians. Patient data including demographics, comorbidities, vital signs, medications and laboratory tests were collected. Patients were followed up till April This article is protected by copyright. All rights reserved 6 (2 months after the last admission) to collect their outcomes including survival and death. Serum alanine aminotransferase (ALT, upper Statistical analyses were performed using SPSS version 26.0. Patients were divided into two groups (normal group and elevated group) based on their serum ALT levels during hospital stay. The normality of continuous variables was tested using the Kolmogorov-Smirnov test. Categorical and continuous variables were summarized as counts (percentage) and median (interquartile range), respectively. Difference between two groups was tested by hypothesis testing using Mann-Whitney U test or Chi-squared test. Spearman correlation was used to evaluate the correlations between aminotransferases and other variables. All significance levels were computed for 2-tailed testing and the cutoff of significance was set at P < 0.05. Among the 330 included patients, elevated ALT levels during hospitalization were found in 96 (29.1%) cases and they were classified into the elevated group, while the rest 234 cases with normal ALT levels were categorized into the normal group. As described in Table 1 , there were significantly fewer females (40.6% vs. 54.7%, P=0.020) and more critical cases (30.2% vs 19.2%, P=0.026) in the elevated group compared with the normal group. No significant difference in age, incidences of common comorbidities and days from onset to admission was found between the two groups. The mortality in the elevated group was not significantly different from that in the normal group. In addition, no evident This article is protected by copyright. All rights reserved difference in vital signs on admission including heart rate, blood pressure and respiration rate was observed between the two groups. The highest body temperatures during the whole cause of disease were compared between the two groups and no difference was found, either. Table 2 interleukin-6 and biomarkers for kidney injury or cardiac injury was found between the two groups. Spearman correlation was used to analyze the relationship between aminotransferases and indices of bacterial infection on admission (Supplementary Table 1 ). Both serum ALT and AST were positively correlated with indices for bacterial infection including white blood cell count, neutrophil count, C-reactive protein and procalcitonin. Specifically, serum ALT concentration was positively correlated with neutrophil count (r = 0.219, P < .001) and procalcitonin (r = 0.168, P = .003). And similar correlations with neutrophil count (r = 0.165, P = .003) and procalcitonin (r = 0.372, P < .001) were also found for serum AST concentration. Medications prescribed during hospital stay in patients with normal and elevated ALT levels were compared in Table 3 . Compared to patients with normal ALT levels, the medications used in patients with elevated ALT levels were not significantly different, such as antivirals, antibiotics, immunomodulatory drugs and traditional Chinese medicine. This article is protected by copyright. All rights reserved The recovery of serum ALT levels to normal range frequently occurred at 16-20 days or 31-35 days after disease onset. As illustrated in Plot B of Figure 2 , typically the serum AST concentrations increased rapidly to their maximum and then recovered to normal levels, with a shape of inverted "V". And the elevation of serum ALT levels persisted for a median of 12 days (IQR 7-17 days). The present study illustrates the profiles of liver function abnormalities in COVID-19. Liver function abnormalities were commonly observed in COVID-19. [3] [4] [5] [6] 9 The reported incidence of liver function damage in COVID-19 was 14%-52% in previous studies. 7, 8 Since ALT is the most representative index of liver injury, it was used as the basis for grouping in the present study. In the present study, 96 (29.1%) of the 330 elderly This article is protected by copyright. All rights reserved COVID-19 patients had serum ALT elevation. There were more critical cases and more males in patients with elevated ALT. Consistent with our findings, ALT levels were found to be higher in COVID-19 patients who needed ICU care 6, 12 , and liver function damage was more prevalent in male gender. 13 A lower incidence of liver dysfunction (3.75%) was reported in a study focusing on the imported cases of COVID-19 in Jiangsu province of China, 14 in which the included patients were relatively younger (median age 46.1 years) and milder (96.3% of the cases were mild or moderate) compared with the present study. Moreover, other indices related to abnormal liver function, including decreased ALB, elevated AST, LDH and GGT, were also frequently observed in patients with elevated ALT. There are several possible mechanisms related to liver dysfunctions in COVID-19. betacoronavirus that binds to the angiotensin converting enzyme 2 (ACE2) receptor to invade human target cells, similar to severe acute respiratory syndrome (SARS) coronavirus. 1, 15 Liver injury was also reported in patients with SARS. 16, 17 Single cell sequencing revealed that ACE2 was mainly expressed in cholangiocytes, while scarcely expressed in hepatocytes, 13 suggesting that the virus might directly bind to ACE2 positive cholangiocytes, thus cause the liver function abnormalities. Alterations of systemic inflammation and immunity were also supposed to be responsible for the liver dysfunction in COVID-19. 8,13 Lymphopenia occurred within the first two weeks of illness in SARS patients. 18 Likewise, in severe cases with middle east respiratory syndrome (MERS), which was induced by another coronavirus (MERS-CoV), serum levels of cytokine and chemokine also elevated in the early two weeks. 19 In the present study, most of the ALT elevations were begin within 1-3 weeks after symptoms onset. These temporal correlations may indicate a possible involvement of immune disorders and inflammation in the damage of liver function. However, the detail mechanisms need to be further investigated. Hypoxemia may also be a cause of liver damage. 20 Hypoxemia induced by pneumonia is one of the main features of COVID-19, the degree of hypoxemia is used as This article is protected by copyright. All rights reserved the clinical classification criterion for COVID-19 patients. In the present study, there were more severe cases in patients with elevated ALT, indicating the possible influence of hypoxemia on liver damage. In addition, bacterial infection may play a role in liver function abnormalities in COVID-19. The cytokines, reactive oxygen species and nitric oxide released by Kupffer cells, which help to clear the bacteria and endotoxins invading into the portal vein system, might cause injury of the hepatocytes. And cytokines produced by neutrophils could induce further hepatocyte damages. 21 In the present study, indices of bacterial infection were significant higher in the patients with elevated ALT, including the counts of white blood cells and neutrophils, serum C-reactive protein and procalcitonin levels. And significant positive correlations were found between those indices and aminotransferases. These results suggested a close relationship between bacterial infection and liver function abnormalities. Furthermore, medications such as antivirals or antibiotics may cause damage to liver function. However, no significant difference in medications was found between patients with normal and elevated ALT levels in the present study. It should be noted that there was a high proportion of male genders in patients with elevated ALT, which may be related to the gender differences in ACE2 expression or lifestyles such as smoking. However, more research is needed to elucidate this phenomenon. reported in several studies. ALT elevation in SARS patients occurred during the first two weeks after disease onset, 16, 22 and started to recover after two weeks. 22 Most of the liver injuries in SARS patients were mild or moderate. 7,16 Increases of ALT, AST and LDH were also noted in patients with MERS. 23 In a transgenic mouse model of human dipeptidyl peptidase-4, the receptor of MERS-CoV, mild to moderate liver damage was observed on day 5 after infection with MERS-CoV. 24 In the present study, we showed that most of the This article is protected by copyright. All rights reserved temporal changes of ALT levels, the elevation of ALT mostly occurred within three weeks from disease onset and recovered within about five weeks. Several limitations should be noted for this study. As a retrospective study, the indices for liver functions were not determined with a fixed time interval. In addition, the medications taken before admission such as antivirals were difficult to retrieve, which might contribute to the liver function abnormalities on admission. Liver function abnormalities were observed in 29.1% of the elderly COVID-19 patients, which were slightly and transient in most cases. Liver function abnormalities in COVID-19 may be correlated with bacterial infection. This article is protected by copyright. All rights reserved Tables Table 1 This article is protected by copyright. All rights reserved Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding World Health Organization Clinical Characteristics of Coronavirus Disease 2019 in China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Clinical Characteristics of 138 Hospitalized Patients With Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Clinical characteristics of Non-ICU hospitalized patients with coronavirus disease 2019 and liver injuryA Retrospective study Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19 Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome SARS Immunity and Vaccination Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection Hypoxic liver injury Liver dysfunction in sepsis ×10 9 /L, median (IQR) Urea, mmol/L, median (IQR) pg/mL, median (IQR) C-reactive protein, mg/L, median The authors declare that there is no conflict of interests. This article is protected by copyright. All rights reserved Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int 2020.